Enterprise Partners Funding Venture Capital 
socalTECH
AUGUST 19, 2010
San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today.
socalTECH
FEBRUARY 2, 2018
Anzu Partners , a venture capital and private equity investors focused on industrial technology with offices in the San Diego area, has quietly raised $128.4M in its first venture capital fund. The company--which has offices in La Jolla, plus Massachusetts, Florida, and Washington, DC.--revealed
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
MAY 7, 2012
San Diego-based Celladon , a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said today. and Venrock. and Venrock. READ MORE>>.
socalTECH
AUGUST 10, 2021
Solana Beach-based Wildfire Systems, which develops technology used for powering reward and loyalty programs, has raised $15M in a Series A funding, according to the company. Wildfire is led by founder and CEO Jordan Glazier, who is a technology vet, having served at eBay and also been the CEO of Eventful.
socalTECH
AUGUST 14, 2018
in a funding round. The funding was led by Health Enterprise Partners (HEP), and also included Nashville Capital Network and other existing investors. Santa Barbara-based AxiaMed , which is developing healthcare payments technology, said late Tuesday afternoon that it has raised $12.4M
socalTECH
OCTOBER 1, 2009
A quick analysis by socalTECH of our tracking of venture capital deals in Southern California finds that there was around $879M in venture funding activity here in Q3. The biggest are for venture activity in the quarter was Biopharmaceuticals, which was $299.13M of the quarterly total.
socalTECH
FEBRUARY 16, 2012
The round was led by Pfizer Venture Investments, and also included Lundbeckfond Ventures, Novartis Venture Funds, H&Q Healthcare/Life Sciences Investors, and GBS Venture Partners--all new investors--along with prior investors Enterprise Partners Venture Capital, Johnson & Johnson Development Corporation, and Venrock Associates.
Expert insights. Personalized for you.
154 
Let's personalize your content